Univest
Univest
  • Markets
  • Amanta Healthcare Analyst Review 2027: Profit Up Fourfold as the Stock Nears Its High

    • November 19, 2026
    • Posted by: Ankit Jaiswal
    • Category: Market
    No Comments
    Amanta Healthcare Analyst Review 2027: Profit Up Fourfold as the Stock Nears Its High

    Amanta Healthcare grew Q2 FY27 revenue 17% to ₹83.13 crore with EBITDA margin of 21.6%, and profit rose to ₹4.86 crore from ₹1.21 crore. With no brokerage coverage, we review the IV fluids and sterile injectables business, valuation, debt and risks for 2027.

    read more